Crossmark

A novel Autologous Cytokine-Rich Serum (SARC) to treat knee osteoarthritis patients’ refractory to a previous glucocorticoid intra-articular injection. A pilot study

Crossref DOI link: https://doi.org/10.1016/j.reuma.2025.502016

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Orellana, Cristóbal

Garcia Cirera, Silvia

Rodrigo Parés, Albert

Uriel Brotons, Laia

Arqué Corredor, Àlex

Aymerich, Cristina

Gómez, Rafael

Carreras, Anna

Berenguer-Llergo, Antoni

Calvet, Joan
Funding

Funding for this research was provided by:

Centres de Recerca de Catalunya

Generalitat de Catalunya

Sociedad Española de Reumatología
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01
More Information

This article is maintained by: Elsevier

Article Title: A novel Autologous Cytokine-Rich Serum (SARC) to treat knee osteoarthritis patients’ refractory to a previous glucocorticoid intra-articular injection. A pilot study

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2025.502016

Content Type: article

Copyright: © 2025 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) y Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below